Filing Details

Accession Number:
0001190725-16-000428
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-14 15:16:15
Reporting Period:
2016-06-14
Filing Date:
2016-06-14
Accepted Time:
2016-06-14 15:16:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX Pharmaceutical Preparations (2834) 462693615
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579824 M Charles Baum C/o Mirati Therapeutics Inc.
9393 Towne Centre Drive, Ste 200
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-14 20,000 $7.05 48,556 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.96 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.